Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Income (2019 - 2025)

IDEAYA Biosciences' Net Income history spans 7 years, with the latest figure at -$94.6 million for Q4 2025.

  • For Q4 2025, Net Income rose 34.39% year-over-year to -$94.6 million; the TTM value through Dec 2025 reached -$159.3 million, up 51.28%, while the annual FY2025 figure was -$159.3 million, 51.28% up from the prior year.
  • Net Income for Q4 2025 was -$94.6 million at IDEAYA Biosciences, down from $108.5 million in the prior quarter.
  • Across five years, Net Income topped out at $108.5 million in Q3 2025 and bottomed at -$144.1 million in Q4 2024.
  • The 5-year median for Net Income is -$29.6 million (2022), against an average of -$36.7 million.
  • The largest annual shift saw Net Income tumbled 5179.7% in 2023 before it soared 262.13% in 2025.
  • A 5-year view of Net Income shows it stood at -$18.4 million in 2021, then plummeted by 43.95% to -$26.4 million in 2022, then crashed by 58.52% to -$41.9 million in 2023, then tumbled by 243.87% to -$144.1 million in 2024, then skyrocketed by 34.39% to -$94.6 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Net Income are -$94.6 million (Q4 2025), $108.5 million (Q3 2025), and -$88.8 million (Q2 2025).